| An Study to Evaluate the Safety and Efficacy of Copanlisib in Combination With Nivolumab in Patients With Advanced Solid Tumors (NCT03735628) | Bayer | 2018-10-17 |
| Venetoclax in Combination With Intensive Induction and Consolidation Chemotherapy in Treatment Naïve AML (NCT03709758) | Dana-Farber Cancer Institute | 2018-10-17 |
| GX-I7 With Cyclophosphamide in Patients With Metastatic or Recurrent Solid Tumors (NCT03733587) | Genexine, Inc. | 2018-10-17 |
| A Study to Investigate Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA Gamma 8) Receptor Occupancy of JNJ-64140284 With Newly Developed Transmembrane AMPA Receptor Regulatory Protein (TARP)-Gamma 8 Positron Emission Tomography (PET) [18F]JNJ-64511070 in Healthy Men (NCT03693391) | Janssen Research & Development, LLC | 2018-10-17 |
| Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Males (Drug Interaction Study and Preliminary Regimen-Finding Study) (NCT04481789) | Shionogi | 2018-10-17 |
| Phase I Study of EOC202 Plus Paclitaxel in Chinese Patients With Metastatic Breast Cancer (NCT03600090) | Taizhou EOC Pharma Co., Ltd. | 2018-10-16 |
| Study to Investigate the Safety and Clinical Activity of GSK3326595 and Other Agents to Treat Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) (NCT03614728) | GlaxoSmithKline | 2018-10-16 |
| Phase I Clinical Study of GB222 to Evaluate the Safety, Tolerability and PK Profiles. (NCT04178057) | Genor Biopharma Co., Ltd. | 2018-10-16 |
| A Study to Investigate the Safety, Efficacy and PK of Multiple Doses of QL-007 in Chronic Hepatitis B Patients in CHINA (NCT03770624) | Qilu Pharmaceutical Co., Ltd. | 2018-10-16 |
| BMS-986205 and Nivolumab as First or Second Line Therapy in Treating Patients With Liver Cancer (NCT03695250) | Edward Kim | 2018-10-16 |
| A Safety and Pharmacokinetic Study of NBM-BMX Administered Orally to Patients With Advanced Cancer (NCT03726294) | NatureWise Biotech & Medicals Corporation | 2018-10-16 |
| DNX-2440 Oncolytic Adenovirus for Recurrent Glioblastoma (NCT03714334) | Clinica Universidad de Navarra, Universidad de Navarra | 2018-10-16 |
| A Phase 1 Study of the Safety and Pharmacokinetics of GC4711 (Oral Capsule) Compared to GC4419 (IV Infusion) and GC4711 (IV Infusion) in Healthy Volunteers (NCT03099824) | Galera Therapeutics, Inc. | 2018-10-16 |
| Surgical Stabilizer Assisted RVC With rtPA for CRVO (NCT03417401) | Universitaire Ziekenhuizen KU Leuven | 2018-10-16 |
| A First in Human Study to Evaluate the Safety and Immune Response to a Vaccine for the Treatment of a Respiratory Virus, When Administered Into the Arm in Healthy Adult Participants (NCT04851977) | Advaccine (Suzhou) Biopharmaceuticals Co., Ltd. | 2018-10-16 |
| Apatinib Combined With S-1 for the Treatment of Recurrent/Metastatic Head and Neck Malignancies (NCT03654612) | China International Medical Foundation | 2018-10-16 |
| Bioequivalence Study of Propofol Medium and Long Chain Fat Emulsion Injection in Healthy Chinese Subjects (NCT07057609) | Haisco Pharmaceutical Group Co., Ltd. | 2018-10-16 |
| Personalized Tumor Vaccine Strategy and PD-1 Blockade in Patients With Follicular Lymphoma (NCT03121677) | Washington University School of Medicine | 2018-10-16 |
| A Study to Investigate the Safety of AB680 in Healthy Volunteers (NCT03677973) | Arcus Biosciences, Inc. | 2018-10-16 |
| Study of TG6002 (VV TK-RR-FCU1) in Combination With 5-FC in Patients With Advanced Gastro-intestinal Tumors. (NCT03724071) | Transgene | 2018-10-16 |
| Study of TRPH-222 in Patients With Relapsed and/or Refractory B-Cell Lymphoma (NCT03682796) | Triphase Research and Development III Corp. | 2018-10-15 |
| Managing Vascular Dementia Risk Factors With SymTrend (NCT03702543) | SymTrend Inc. | 2018-10-15 |
| A Study to Assess the Safety and Pharmacokinetics of Oral Sodium Oligo-mannurarate (GV-971) in Healthy Chinese Subjects (NCT03715114) | Shanghai Greenvalley Pharmaceutical Co., Ltd. | 2018-10-15 |
| A Research Study of NNC0165-1875 Alone or Together With Semaglutide in People Who Are Overweight or Obese (NCT03707990) | Novo Nordisk A/S | 2018-10-15 |
| A Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors (NCT03708328) | Hoffmann-La Roche | 2018-10-15 |
| A Study Combining Personalized Neoantigen-based Dendritic Cell Vaccine With Microwave Ablation for the Treatment of Hepatocellular Carcinoma (NCT03674073) | Chinese PLA General Hospital | 2018-10-15 |
| Study to Evaluate the Safety and Efficacy of Anti-CD38 CAR-T in Relapsed or Refractory Multiple Myeloma Patients (NCT03464916) | Sorrento Therapeutics, Inc. | 2018-10-15 |
| The Study of the Safety, Reactogenicity and Immunogenicity of the GamFluVac (NCT03651544) | Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation | 2018-10-15 |
| A Study to Evaluate Safety/Tolerability of Immunotherapy Combinations in Participants With Triple-Negative Breast Cancer or Gynecologic Malignancies (NCT03719326) | Arcus Biosciences, Inc. | 2018-10-15 |
| A Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Pelacarsen (ISIS 681257) in Healthy Japanese Participants (NCT05337878) | Ionis Pharmaceuticals, Inc. | 2018-10-15 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Norketotifen in Healthy Subjects (NCT03712163) | Emergo Therapeutics, Inc. | 2018-10-15 |
| Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer (NCT03709082) | University of Kansas Medical Center | 2018-10-15 |
| Study of ASLAN004 in Healthy Subjects (NCT03721263) | ASLAN Pharmaceuticals | 2018-10-15 |
| Tinostamustine Conditioning and Autologous Stem Cell (NCT03687125) | Mundipharma-EDO GmbH | 2018-10-15 |
| Induction of Immune-mediated aBscOpal Effect thrOugh STEreotactic Radiation Therapy in Metastatic Melanoma Patients Treated by PD-1 + CTLA-4 Inhibitors (BOOSTER MELANOMA) (NCT03354962) | Institut Claudius Regaud | 2018-10-15 |
| A Study to Compare the Blood Level of Bimekizumab Injected Subcutaneously Either by a Prefilled Syringe or by an Auto-injector in Adult Healthy Volunteer Participants (NCT03707717) | UCB Biopharma S.P.R.L. | 2018-10-15 |
| Local Antioxidant Therapy Vasoconstriction Effects in Different Races (NCT03684213) | The University of Texas at Arlington | 2018-10-15 |
| Allogenic Cord Blood Transfusion in Patients With Autism (NCT03786744) | State-Financed Health Facility "Samara Regional Medical Center Dinasty" | 2018-10-12 |
| Bioequivalence Evaluation of Two Fixed-dose Combination of Lisinopril 10mg/Levamlodipine Besylate 5mg in Healthy Chinese Subjects (NCT04885660) | The Affiliated Hospital of Qingdao University | 2018-10-12 |
| A Study to Assess the Safety, Reactogenicity and Immune Response of CureVac's Candidate Rabies mRNA Vaccine in Healthy Adults (NCT03713086) | CureVac | 2018-10-12 |
| Evaluate the Safety, Tolerance, and Pharmacokinetic Profiles of Timolol Maleate Gel (NCT06824948) | Auson Pharmaceuticals Inc. | 2018-10-12 |
| Nivolumab and Ipilimumab After Donor Stem Cell Transplant in Treating Patients With High Risk Refractory or Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome (NCT03600155) | M.D. Anderson Cancer Center | 2018-10-11 |
| Glucophage Extended Release (GXR) China Bioequivalence Study (Nantong - Darmstadt) (NCT03566810) | Merck KGaA, Darmstadt, Germany | 2018-10-11 |
| Safety and Efficacy Study of Sintilimab Combined With IBI305 in Patients With Advanced Hepatocellular Carcinoma (NCT04072679) | Chinese Academy of Medical Sciences | 2018-10-11 |
| Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy (NCT03630991) | M.D. Anderson Cancer Center | 2018-10-11 |
| Dendritic Cell/AML Fusion Cell Vaccine Following Allogeneic Transplantation in AML Patients (NCT03679650) | Beth Israel Deaconess Medical Center | 2018-10-11 |
| Nivolumab and BMS-986253 for Hormone-Sensitive Prostate Cancer (MAGIC-8) (NCT03689699) | Mark Stein | 2018-10-11 |
| Study of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer. (NCT03616587) | AstraZeneca | 2018-10-11 |
| Phase 1 Study to Evaluate ASN002 Absorption, Metabolism, and Excretion of [14C] Following a Single Oral Dose in Healthy Male Subjects (NCT03641573) | Asana BioSciences | 2018-10-11 |
| A Taste Assessment of BMS-986165 in Healthy Participants (NCT03751228) | Bristol-Myers Squibb | 2018-10-11 |
| A Food Effect Study to Assess Pharmacokinetics of Hemay005 in Healthy Volunteers (NCT03577626) | Tianjin Hemay Bio-Tech Co., Ltd | 2018-10-10 |
| A Clinical Study of PD-L1 Antibody ZKAB001(Drug Code) in Limited Stage of High-grade Osteosarcoma (NCT03676985) | Lee's Pharmaceutical Limited | 2018-10-10 |
| A Safety Study of Tucatinib in Healthy and Hepatically-Impaired Subjects (NCT03722823) | Seagen Inc. | 2018-10-10 |
| Study of LY3074828 in Healthy Participants (NCT03748940) | Eli Lilly and Company | 2018-10-10 |
| A Phase 1b Study of STMC-103H in Multi-Sensitized Allergic Subjects Who Are Otherwise Healthy (NCT03819881) | Siolta Therapeutics, Inc. | 2018-10-10 |
| Study of Dosage Exploration and Pharmacokinetics for HA121-28 Tablets (NCT03994484) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2018-10-10 |
| A Clinical Study of PD-L1 Antibody ZKAB001（Drug Code） in Locally Advanced and Metastatic Urothelial Carcinoma (NCT03676946) | Lee's Pharmaceutical Limited | 2018-10-10 |
| DKN-01 Inhibition in Advanced Liver Cancer (NCT03645980) | Johannes Gutenberg University Mainz | 2018-10-10 |
| Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females (NCT03676101) | Shanghai Bovax Biotechnology Co., Ltd. | 2018-10-10 |
| Single and Multiple Ascending Dose and Food Effect PK Study in Healthy Adult and Elderly Subjects (NCT03668314) | Alkermes, Inc. | 2018-10-10 |
| Pharmacokinetically-guided on the Individualization of Pembrolizumab Administration in the Treatment of Lung Cancer (NCT05226728) | Sun Yat-sen University | 2018-10-10 |
| Study of Tisagenlecleucel in Combination With Pembrolizumab in r/r Diffuse Large B-cell Lymphoma Patients (NCT03630159) | Novartis Pharmaceuticals | 2018-10-09 |
| Safety and Tolerability of an Antibody Against Zika Virus (Tyzivumab) in ZIKV Infected Patients (NCT03776695) | Tychan Pte Ltd. | 2018-10-09 |
| Phase 1 Study of TAK-831 in Healthy Adult Asian Subjects (NCT03687684) | Neurocrine Biosciences | 2018-10-09 |
| cAd3-Marburg Vaccine in Healthy Adults (NCT03475056) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-10-09 |
| First in Human Study to Assess Safety of VIS649 in Healthy Subjects (NCT03719443) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2018-10-09 |
| Phase I Study of HMPL-523+Azacitidine in Elderly Patients With Acute Myeloid Leukemia (NCT03483948) | Hutchison Medipharma Limited | 2018-10-09 |
| Trial of Trametinib and Ponatinib in Patients With KRAS Mutant Advanced Non-Small Cell Lung Cancer (NCT03704688) | Memorial Sloan Kettering Cancer Center | 2018-10-09 |
| The Mass Balance and Biotransformation of [14C]Donafenib in Healthy Adult Man (NCT04816123) | Suzhou Zelgen Biopharmaceuticals Co.,Ltd | 2018-10-09 |
| This Study in Healthy Volunteers Determines the Amount of BI 730460 in the Blood When Taken as Tablet. It Looks at How Different Doses of BI 730460 Are Taken up in the Body and How Well They Are Tolerated. The Study Also Tests How Food Influences the Amount of BI 730460 in the Blood. (NCT03483077) | Boehringer Ingelheim | 2018-10-09 |
| Safety and Efficacy of AS101 1% Oral Solution in Patients With Neovascular Age-Related Macular Degeneration (AMD) (NCT03216538) | Feramda | 2018-10-08 |
| Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas (NCT03715933) | Inhibrx Biosciences, Inc | 2018-10-08 |
| A Personal Cancer Vaccine (NEO-PV-01) and APX005M or Ipilimumab With Nivolumab in Patients With Advanced Melanoma (NCT03597282) | BioNTech US Inc. | 2018-10-08 |
| Dapagliflozin Effects on Hypoglycemia (NCT03704818) | University of California, San Diego | 2018-10-08 |
| A Bioequivalence Study of Valsartan / Amlodipine From Valsartan and Amlodipine Tablets (Hua Yuan Pharmaceutical LLC, China) and Valsartan and Amlodipine Tablets (Ⅰ) (Novartis Pharma Schweiz AG, Switzerland) (NCT04085627) | Second Affiliated Hospital of Wenzhou Medical University | 2018-10-08 |
| Safety Issues of Peribulbar Injection of UC-MSC in Patients With Retinitis Pigmentosa (NCT04315025) | PT. Prodia Stem Cell Indonesia | 2018-10-07 |
| MK-8583 Single Dose Study in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants (MK-8583-002) (NCT03552536) | Merck Sharp & Dohme LLC | 2018-10-07 |
| Clinical Trial to Compare the Safety and Pharmacokinetics of YH22162 in Healthy Volunteers (NCT03662620) | Yuhan Corporation | 2018-10-05 |
| Compare the Pharmacokinetic of K-877 Controlled Release (CR) and Immediate Release (IR) Tablets in Healthy Adults. (NCT03702673) | Kowa Research Institute, Inc. | 2018-10-05 |
| A Study to Compare the Amount of Meloxicam in the Blood When it is Taken as Capsules or as Tablets (NCT03684265) | Boehringer Ingelheim | 2018-10-05 |
| Cytomegalovirus (CMV) RNA-Pulsed Dendritic Cells for Pediatric Patients and Young Adults With WHO Grade IV Glioma, Recurrent Malignant Glioma, or Recurrent Medulloblastoma (NCT03615404) | Gary Archer Ph.D. | 2018-10-05 |
| Assessment of the Biodistribution and Safety of [18F]MNI-1054 (NCT03719482) | Invicro | 2018-10-05 |
| Effect of Venglustat in Patients With Renal Impairment (NCT03687554) | Genzyme, a Sanofi Company | 2018-10-05 |
| A Renal Impairment Study for PF-04965842 (NCT03660241) | Pfizer | 2018-10-05 |
| Absorption, Metabolism and Excretion (AME) Study of [14C]EDP-305 in Healthy Male Subjects (NCT03748628) | Enanta Pharmaceuticals, Inc | 2018-10-05 |
| A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment (NCT03428958) | NuCana plc | 2018-10-05 |
| Study of Excretion Balance and Pharmacokinetics of [14C]-Sodium Valproate (3.7 MBq) in Healthy Postmenopausal or Permanently Sterile Female Subjects (NCT03681158) | Sanofi | 2018-10-05 |
| PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors (NCT03685591) | Pfizer | 2018-10-04 |
| A Study to Assess Administration of an Oral Anti-thrombotic With Antiplatelet Therapy in Healthy Subjects (NCT03698513) | Bristol-Myers Squibb | 2018-10-04 |
| The PK Characteristics of the Co-administration of Metformin SR and Rosuvastatin and JLP-1310 in Healthy Male Volunteers. (NCT03690778) | Jeil Pharmaceutical Co., Ltd. | 2018-10-04 |
| Rebalancing the Serotonergic System in Cocaine Dependence (NCT03266939) | Mclean Hospital | 2018-10-04 |
| Study of Safety and Efficacy of Betalutin and Rituximab in Patients With FL (NCT03806179) | Nordic Nanovector | 2018-10-04 |
| Evaluate the Safety, Tolerability, & Pharmacokinetics of K-285 Compared With Indomethacin Capsule in Healthy Adults (NCT03712241) | Kowa Research Institute, Inc. | 2018-10-04 |
| A Study of Perpetrator Drug Interactions of Enasidenib in AML Patients (NCT03720366) | Celgene | 2018-10-04 |
| The Effect Of An Anesthetic Procedure On Post Operative Pain Management In Carpal Tunnel Release (NCT03729375) | University of South Florida | 2018-10-04 |
| Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma (NCT03126630) | National Cancer Institute (NCI) | 2018-10-04 |
| A Trial for Treatment of Cancer Patients With Multiple Brain Metastases Undergoing Whole-Brain Radiotherapy (NCT03608020) | BioMimetix JV, LLC | 2018-10-04 |
| Stereotactic Body Radiation Therapy and Durvalumab With or Without Tremelimumab Before Surgery in Treating Participants With Human Papillomavirus Positive Oropharyngeal Squamous Cell Caner (NCT03618134) | Jonsson Comprehensive Cancer Center | 2018-10-04 |
| Combination of Nivolumab Immunotherapy With Radiation Therapy and Androgen Deprivation Therapy (NCT03543189) | H. Lee Moffitt Cancer Center and Research Institute | 2018-10-03 |
| Malaria: Relative Bioavailability and Food Effect of DSM265 (NCT03637517) | Medicines for Malaria Venture | 2018-10-03 |